I am not sure but i think the NS5A inhibitor that [Presidio] are making good progress with is not the one they bought [from XTLB] but may be a derivative of that compound.
I didn’t know that. Do you have a source for this info? T.i.a.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”